Altered iron metabolism as a target for ferroptosis induction in head and neck cancer

被引:0
作者
Jaewang Lee
Jong-Lyel Roh
机构
[1] CHA Bundang Medical Center,Department of Otorhinolaryngology
[2] CHA University,Head and Neck Surgery
[3] CHA University,Department of Biomedical Science, General Graduate School
来源
Cellular Oncology | 2023年 / 46卷
关键词
Iron; Labile iron pool; Ferroptosis; Regulators; Head and neck cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Iron is a mineral micronutrient essential for survival and vital functions in many biological processes in living organisms. Iron plays a crucial role as a cofactor of iron-sulfur clusters in energy metabolism and biosynthesis by binding with enzymes and transferring electrons to targets. Iron can also impair cellular functions by damaging organelles and nucleic acids by producing free radicals from redox cycling. Iron-catalyzed reaction products can induce active-site mutations in tumorigenesis and cancer progression. However, the boosted pro-oxidant iron form may contribute to cytotoxicity by increasing soluble radicals and highly reactive oxygen species via the Fenton reaction. An increased redox-active labile iron pool is required for tumor growth and metastasis, but the increased cytotoxic lipid radicals also lead to regulated cell death, such as ferroptosis. Therefore, this may be a major target for selectively killing cancer cells. This review intends to understand altered iron metabolism in cancers and discuss iron-related molecular regulators highly associated with iron-induced cytotoxic radical production and ferroptosis induction, focusing on head and neck cancer.
引用
收藏
页码:801 / 810
页数:9
相关论文
共 50 条
[21]   Ferroptosis-Related Genes Are Associated with Radioresistance and Immune Suppression in Head and Neck Cancer [J].
Huang, Ping ;
Ning, Xuejian ;
Kang, Min ;
Wang, Rensheng .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (03) :100-113
[22]   Targeting ferroptosis suppressor protein 1 in cancer therapy: Implications and perspectives, with emphasis on head and neck cancer [J].
Roh, Jong-Lyel .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 202
[23]   Lipid metabolism reprogramming in head and neck cancer [J].
Liang, Jinfeng ;
Li, Lin ;
Li, Limei ;
Zhou, Xiaoying ;
Zhang, Zhe ;
Huang, Yi ;
Xiao, Xue .
FRONTIERS IN ONCOLOGY, 2023, 13
[24]   Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration [J].
Masaldan, Shashank ;
Bush, Ashley I. ;
Devos, David ;
Rolland, Anne Sophie ;
Moreau, Caroline .
FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 :221-233
[25]   Iron Metabolism and Ferroptosis in Diabetic Kidney Disease [J].
Mu, Fangxin ;
Luo, Ping ;
Zhu, Yuexin ;
Nie, Ping ;
Li, Bing ;
Bai, Xue .
CELL BIOCHEMISTRY AND FUNCTION, 2025, 43 (04)
[26]   Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis [J].
Lee, Jaewang ;
You, Ji Hyeon ;
Shin, Daiha ;
Roh, Jong-Lyel .
THERANOSTICS, 2020, 10 (17) :7775-7786
[27]   Iron Metabolism and Ferroptosis in Epilepsy [J].
Chen, Shuang ;
Chen, Yongmin ;
Zhang, Yukang ;
Kuang, Xi ;
Liu, Yan ;
Guo, Meiwen ;
Ma, Lin ;
Zhang, Daqi ;
Li, Qifu .
FRONTIERS IN NEUROSCIENCE, 2020, 14
[28]   Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity [J].
Luo, Lianxiang ;
Wang, Han ;
Tian, Wen ;
Zeng, Jiayan ;
Huang, Yuru ;
Luo, Hui .
AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11) :5508-5525
[29]   MERTK as a novel therapeutic target in head and neck cancer [J].
von Maessenhausen, Anne ;
Sanders, Christine ;
Thewes, Britta ;
Deng, Mario ;
Queisser, Angela ;
Vogel, Wenzel ;
Kristiansen, Glen ;
Duensing, Stefan ;
Schroeck, Andreas ;
Bootz, Friedrich ;
Brossart, Peter ;
Kirfel, Jutta ;
Heasley, Lynn ;
Braegelmann, Johannes ;
Perner, Sven .
ONCOTARGET, 2016, 7 (22) :32678-32694
[30]   Induction chemotherapy for locally advanced head and neck cancer [J].
Calais, G. ;
Chapet, S. ;
Ruffier-Loubiere, A. ;
Bernadou, G. .
CANCER RADIOTHERAPIE, 2013, 17 (5-6) :498-501